Crestor | Heart Disease Drug
Crestor®
(generic name: rosuvastatin) is a widely-prescribed drug from the class of statins, used to treat high
cholesterol and to prevent heart disease. Crestor, made by AstraZeneca,
and was FDA-approved and launched in 2003 and was prescribed
to more than four million patients by the end of 2004.When Crestor was first before the FDA (Food and Drug Administration) for approval, the process was delayed due to safety concerns. These concerns included kidney damage, as well as a potentially-fatal condition known as rhabdomyolysis. Rhabdomyolysis is a breakdown of muscle fibers which results in kidney damage due to muscle content entering the bloodstream.
Since its introduction, there have been reports of kidney damage, renal failure, rhabdomyolysis and at least one death.
The most common side-effects of alendronate are:
• Weakness
• Nausea, stomach pain, constipation, diarrhea
• Sore throat, runny or stuffy nose
• Headache
• Pain or burning when you urinate.
Less common, but more severe side-effects are listed as:
• Muscle pain, tenderness, or weakness with fever or flu symptoms and dark colored urine
• Urinating more or less than usual, or not at all
• Jaundice (yellowing of the skin or eyes)
• Chest pain
• Swelling in your hands or feet
Signs of possible rhabdomyolysis are:
• Abnormal urine color (dark, red, or cola colored)
• Muscle tenderness
• Weakness of the affected muscle(s)
• Generalized weakness
• Muscle stiffness or aching (myalgia)
• Weight gain (unintentional)
• Seizures
• Joint pain
• Fatigue
If you believe your Crestor use has put you or a loved one in danger, please fill out our Case Review Contact Form to the right on this page to find out what your case is worth.
Dangerous Drugs
News Articles
Pfizer Starts Media Ad Blitz to Address Smoking Drug Concerns
May 28 (Bloomberg) – Pfizer Inc.
(read more..)
North Carolina Case Claims Financial Calamity From Bayer Drug
5/2/08 - Triangle Business Journal
(read more..)
Panel May Issue Subpoenas Related to FDA Approval
on Antibiotic Drug Ketek
1/28/08 - FDA
(read more..)
Second Safety Warning on Fentanyl Skin Patch
12/21/07 - FDA
(read more..)
F.D.A. Investigates Quit-Smoking Drug
11/20/07 - Associated Press
(read
more..)
Merck to Pay $4.85 Billion To Settle Most Vioxx Cases
11/09/07 - AngelReyesBlog.com
(read
more..)
Cephalon Drug Is Tied to Several Deaths
9/14/07 - The Wall Street Journal
(read
more..)
$5.5 Million Award in First Federal Fentanyl (Duragesic) Pain Patch Trial
6/19/07 - Press Release
(read
more...)